Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
International Archives of Allergy and Immunology|May 4, 1999
Modulation of an allergic immune response via the mucosal route in a murine model of inhalative type-I allergyU Wiedermann, B Jahn-Schmid, A Repa, et al.European Journal of Immunology|July 31, 1999
Oligodeoxynucleotides containing CpG motifs induce IL-12, IL-18 and IFN-gamma production in cells from allergic individuals and inhibit IgE synthesis in vitroB Bohle, B Jahn-Schmid, D Maurer, et al.Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 22, 2005
Characterization of the T cell response to the major hazelnut allergen, Cor a 1.04: evidence for a relevant T cell epitope not cross-reactive with homologous pollen allergensB Bohle, A Radakovics, D Lüttkopf, et al.The Journal of Allergy and Clinical Immunology|November 7, 1999
Oligodeoxynucleotides containing CpG motifs modulate the allergic TH2 response of BALB/c mice to Bet v 1, the major birch pollen allergenB Jahn-Schmid, U Wiedermann, B Bohle, et al.International Immunology|June 29, 1999
Suppressive versus stimulatory effects of allergen/cholera toxoid (CTB) conjugates depending on the nature of the allergen in a murine model of type I allergyU Wiedermann, B Jahn-Schmid, M Lindblad, et al.The Journal of Allergy and Clinical Immunology|June 9, 1999
Suppression of antigen-specific T- and B-cell responses by intranasal or oral administration of recombinant bet v 1, the major birch pollen allergen, in a murine model of type I allergyU Wiedermann, B Jahn-Schmid, B Bohle, et al.International Immunology|October 3, 1999
Suppressive versus stimulatory effects of allergen/cholera toxoid (CTB) conjugates depending on the nature of the allergen in a murine model of type I allergyU Wiedermann, B Jahn-Schmid, M Lindblad, et al.Clinical and Experimental Immunology|February 24, 1998
Effects of adjuvants on the immune response to allergens in a murine model of allergen inhalation: cholera toxin induces a Th1-like response to Bet v 1, the major birch pollen allergenU Wiedermann, B Jahn-Schmid, R Fritsch, et al.Journal of Biotechnology|January 26, 1996
Toward selective elicitation of TH1-controlled vaccination responses: vaccine applications of bacterial surface layer proteinsB Jahn-Schmid, P Messner, F M Unger, et al.Allergy|December 23, 2011
Human blood basophils do not act as antigen-presenting cells for the major birch pollen allergen Bet v 1C Kitzmüller, B Nagl, S Deifl, et al.Pageof 3